Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Tolvaptan can slow kidney disease progression, but doesn't affect mortality or kidney failure.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Ruxolitinib treatment may cause eyelash growth.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

JAK inhibitors may help treat alopecia areata in children, but their safety needs careful evaluation.

KY19382 helps regrow hair and create new hair follicles.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Reducing Tyrosinase prevents mature color pigment cells from forming in mouse hair.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Tofacitinib might be used to treat hair loss.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Retinoids or their analogs could treat skin pigmentation disorders like melasma and vitiligo.

Dermatologists are hesitant to prescribe Janus kinase inhibitors for alopecia areata due to safety concerns and lack of knowledge.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

Pyruvate Kinase M2 helps hair grow by linking energy production and a key hair growth pathway.

Janus kinase inhibitors may effectively treat resistant scalp conditions like folliculitis decalvans and dissecting cellulitis.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Tadalafil and Finasteride may help treat aggressive melanoma.